Search filters

List of works by Daniele Santini

"Triple positive" early breast cancer: an observational multicenter retrospective analysis of outcome.

scientific article published on 18 February 2016

'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer

scientific article published on 12 May 2013

'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine

scientific article published on 01 February 2009

'Old' and 'new' drugs for the treatment of cancer pain

scientific article published on March 2013

A giant sarcoma of the parotid gland: a case report and review of the literature.

scientific article published on November 2006

A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss

scientific article published on 04 October 2006

A key opinion leader interview with Prof D Santini: insight into cancer research

scientific article published in March 2015

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study

scientific article

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

scientific article published on 27 February 2019

A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study

scientific article published on January 2005

A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients

scientific article published on 08 December 2006

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).

scientific article

A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer

scientific article

A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer ⬇️

scientific article published on October 20, 2003

A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients

scientific article

A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

scientific article published on 3 October 2007

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience

scientific article published on 25 May 2017

Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials

scientific article published on 17 November 2015

Adjuvant colon cancer chemotherapy: where we are and where we'll go.

scientific article

Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas

scientific article published on 01 September 2007

Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma.

scientific article

Aminobisphosphonate-activated gammadelta T cells in immunotherapy of cancer: doubts no more

scientific article published on 01 July 2008

An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer

scientific article published on 01 January 2006

Analysis of APAF-1 expression in human cutaneous melanoma progression

scientific article

Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells.

scientific article published on September 2012

Anaphylaxis to dexrazoxane (ICRF-187) following three previous uncomplicated infusions

scientific article published in February 2004

Androgen receptor and antiandrogen therapy in male breast cancer ⬇️

scientific article published on 11 August 2015

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

scientific article

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r

scientific article published on 04 February 2020

Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells

scientific article

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review

scientific article published on 22 July 2017

Antiangiogenic properties of metronomic chemotherapy in breast cancer.

scientific article published on April 2007

Antineoplastic drug-induced bradyarrhythmias.

scientific article published on 13 July 2012

Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.

scientific article

Aprepitant against pruritus in patients with solid tumours

scientific article published on 11 June 2010

Aprepitant for erlotinib-induced pruritus

scientific article published on July 2010

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.

scientific article

Are bisphosphonates the suitable anticancer drugs for the elderly?

scientific article published on 08 August 2008

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

Association of thymidylate synthase polymorphisms with gastric cancer susceptibility

scientific article published in December 2004

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.

scientific article

Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial.

scientific article published in October 2009

Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect

scientific article published in March 2003

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

scientific article published on May 2015

Biological interaction between anti-epidermal growth factor receptor agent cetuximab and magnesium

scientific article published on 01 June 2008

Bisphosphonate anticancer activity

scientific article published on 9 March 2011

Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities.

scientific article published in January 2004

Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle

scientific article

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence

scientific article (publication date: 2015)

Bisphosphonates: new antiangiogenic molecules in cancer treatment?

scientific article published on 01 May 2003

Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin

scientific article published on 6 March 2018

Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment.

scientific article published on June 2013

Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion

scientific article published on 01 March 2020

Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma

scientific article

Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions

scientific article published on 21 October 2007

Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?

scientific article

Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options

scientific article published on 17 April 2013

Bone-Targeted Agents

Brain metastatic volume and white matter lesions in advanced cancer patients

scientific article published on 12 May 2013

Brief letter of a doctor to his psychologist in the COVID-19 outbreak era

scientific article published on 01 May 2020

COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables.

scientific article published on 17 February 2006

COX-2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification

scientific article published on 01 June 2007

COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters

scientific article published on 12 August 2006

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

scientific article published on 15 July 2020

Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?

scientific article published on 13 April 2016

Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting.

scientific article published on February 2010

Cancer chronotherapy: principles, applications, and perspectives

scientific article published on 01 August 2003

Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer

scientific article published on 12 October 2006

Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.

scientific article published on 30 September 2013

Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.

scientific article published in January 2013

Case report of a long-surviving man with metastatic renal cell carcinoma treated with pazopanib

scientific article published in March 2014

Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer

scientific article published on July 2005

Cetuximab in small bowel adenocarcinoma: a new friend?

scientific article published on 14 September 2010

Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: clinical outcome according to KRAS and BRAF mutational status.

scientific article published on 8 July 2010

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

scientific article published on 5 March 2012

Cetuximab: from biology to the care of colorectal cancer patients

scientific article published on 01 October 2007

Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib

scientific article published on 4 May 2017

Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours

scientific article published on May 2006

Chemo-immunotherapy: a new option for non-small cell lung cancer

scientific article published on 15 March 2009

Chemotherapy in biliary tract cancer.

scientific article published on April 2010

Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study

scientific article published on 22 October 2020

Chemotherapy-induced steatohepatitis in colorectal cancer patients

scientific article published in December 2006

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

scientific article

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.

scientific article published on 28 March 2011

Cigarettes smoking habit may reduce benefit from cetuximab-based treatment in advanced colorectal cancer patients.

scientific article

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

scientific article

Classic Kaposi Sarcoma: to treat or not to treat?

scientific article

Classification of biliary tract cancer (BTC): evaluation of all entities

scientific article published on 01 June 2009

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

scientific article published on 25 October 2014

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

scientific article published on 22 February 2019

Clinical features of male breast cancer and multimodal treatment: a comment to retrospective survey analysis at Italian centers

scientific article published on 01 July 2014

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

scientific article

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50

scientific article published on 30 May 2020

Colorectal carcinomas and PTEN/MMAC1 gene mutations

article

Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens

scientific article published on 28 February 2013

Complete pathological response after FOLFIRINOX for locally advanced pancreatic cancer. The beginning of a new era? Case report and review of the literature.

scientific article published on 19 July 2014

Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient

scientific article published on 01 November 2004

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma

scientific article

Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients.

scientific article published on 28 July 2005

Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

scientific article published on 25 September 2015

Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer.

scientific article

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients

scientific article published on 21 February 2019

Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients

scientific article published on 01 May 2005

Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

scientific article

Denosumab: the era of targeted therapies in bone metastatic diseases

scientific article

Deregulation of dicer and mir-155 expression in liposarcoma.

scientific article published in April 2015

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

scientific article

Developing drugs in cancer-related bone pain

scientific article published on 25 August 2017

Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients

scientific article

Differences in terms of progression-free survival (PFS) and overall survival (OS) in patients treated with first-line sorafenib, sunitinib, and pazopanib for late relapsing (>5 years) renal cell carcinoma

Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases

scientific article

Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting

scientific article published on 15 July 2013

Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

scientific article published on 07 August 2019

Distribution of the serine protease HtrA1 in normal human tissues

scientific article (publication date: October 2003)

Do we need biopsies of metastases for colorectal cancer patients?

scientific article published on 7 July 2009

Docetaxel induced pericardial effusion.

scientific article published in September 2007

Dramatic improvement of psoriasis with gemcitabine monotherapy

scientific article published in December 2003

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

scientific article

Drug-induced hepatotoxicity in cancer patients - implication for treatment

scientific article published on 27 May 2016

EGF-receptor targeting with monoclonal antibodies in colorectal carcinomas: rationale for a pharmacogenomic approach

scientific article published on January 2008

Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice

scientific article published on 15 November 2019

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

scientific article published on 29 November 2010

Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome

scientific article published on July 2008

Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenib

scientific article published on 5 January 2010

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

scientific article published on 16 November 2020

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

scientific article

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

scientific article published on 22 September 2013

Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy.

scientific article published on 6 July 2018

Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): a phase 3, open-label, randomised, non-inferiority trial

scientific article published on 16 May 2013

Emerging Therapeutic Targets in Osteoncology ⬇️

scientific article published on 04 July 2011

Emerging anti-cancer molecular mechanisms of aminobisphosphonates

scientific article

Emerging concepts on drug resistance in bladder cancer: Implications for future strategies.

scientific article published on 15 May 2015

Emerging drugs for the treatment of bone metastasis.

scientific article published on 25 June 2015

Emerging kinase inhibitors of the treatment of gastric cancer

scientific article published on 28 May 2015

Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma.

scientific article published on 27 January 2014

Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients (Br J Surg 2003; 90: 547-548).

scientific article published in September 2003

European Society for Medical Oncology 2006: meeting highlights on targeted therapies. Istanbul, Turkey, 29 September-3 October 2006

scientific article published on 01 February 2007

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

scientific article published on 07 January 2020

Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study

scientific article published on 16 May 2020

Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid

scientific article published on 18 September 2012

Evidence-based guidelines: Improving AGREEment on consistence evaluation

scientific article

Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma

scientific article published on 24 October 2012

Expression of surface protein receptors in lung cancer

scientific article published on 01 November 2002

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases

scientific article published in March 2011

Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study

scientific article published on 6 September 2017

Fatal thrombocytopenia and thrombocytopathia: an unusual onset of non-small cell lung cancer.

scientific article

Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress

scientific article

Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.

scientific article published on November 2003

First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab

scientific article published on 18 February 2009

Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study

scientific article published in September 2002

Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study

scientific article

Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis

scientific article

Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan

scientific article

Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy.

scientific article

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

scientific article

Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?

scientific article published on 27 July 2015

Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside

scientific article published on March 2014

High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice

scientific article published on 01 July 2010

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice

scientific article published on 04 December 2008

High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease

scientific article

Hormono-biological therapy in metastatic breast cancer: preclinical evidence, clinical studies and future directions

scientific article published on 01 February 2008

Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy.

scientific article published in September 2010

HtrA1, a potential predictor of response to cisplatin-based combination chemotherapy in gastric cancer

scientific article published on 30 March 2011

Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC).

scientific article published on January 2011

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer

scientific article

Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.

scientific article

Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma

scientific article published on 22 June 2017

Hypoxia inducible factor-1 expression mediates myocardial response to ischemia late after acute myocardial infarction

article

Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV.

scientific article published on 30 November 2012

Identification of genes down-regulated during melanoma progression: a cDNA array study

scientific article published on April 2003

Idiosyncratic reaction after oxaliplatin infusion

scientific article published in January 2001

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

scientific article published on 24 September 2015

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

scientific article published on 22 June 2020

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

scientific article published on 24 August 2016

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

scientific article published on 21 June 2020

Immunotherapeutic approaches for hepatocellular carcinoma

scientific article

Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

scientific article published on 15 January 2020

Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain

scientific article

In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas

scientific article

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients

scientific article published on 6 May 2008

Increased apoptosis in remote non-infarcted myocardium in multivessel coronary disease

article published in 2004

Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

scientific article published on 19 October 2014

Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium

scientific article

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

scientific article published on 01 November 2020

Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype.

scientific article

Interleukin 1beta-511T gene (IL1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis

scientific article published in November 2008

Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma

scientific article

Interventional Radiologist's perspective on the management of bone metastatic disease

scientific article published on 03 June 2015

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

article

Inverse spatial distribution of brain metastases and white matter hyperintensities in advanced lung and non-lung cancer patients

scientific article published on 22 July 2014

Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer

scientific article

Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis

scientific article

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GI

scientific article published on 17 April 2019

Ischemia and apoptosis in an animal model of permanent infarct-related artery occlusion

article

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

scientific article published on 14 July 2009

KRAS mutations and sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal carcinoma: an open issue

scientific article published on 01 May 2009

Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study

scientific article published on 3 August 2015

Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan

scientific article published on 21 September 2005

Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?

scientific article

Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study

scientific article published on 23 May 2020

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

scientific article

Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor.

scientific article

Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience

scientific article published on 25 June 2015

Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients

scientific article published on 5 November 2009

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

scientific article published on 23 December 2014

MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients

scientific article published on 01 June 2009

Magnesium: are we better off without it?

scientific article published in October 2013

Management of cancer pain: ESMO Clinical Practice Guidelines

scientific article published on 01 October 2012

Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.

scientific article

Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.

scientific article published on 14 August 2007

Mechanisms of disease: Preclinical reports of antineoplastic synergistic action of bisphosphonates

scientific article

Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer

scientific article

Metabolic alterations in renal cell carcinoma

scientific article published on 09 July 2015

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

scientific article published on 15 May 2015

Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.

scientific article published in February 2006

Metronomic chemotherapy from rationale to clinical studies: a dream or reality?

scientific article published on 20 January 2015

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

scientific article (publication date: 15 September 2015)

MicroRNAs and bone metastasis: a new challenge.

scientific article published on 11 July 2014

Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry

scientific article published on 6 March 2014

Molecular prognostic factors in patients with pancreatic cancer.

scientific article published on December 2007

Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma

scientific article

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.

scientific article

Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat.

scientific article

NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.

scientific article published on 4 May 2009

Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.

scientific article published on March 2012

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.

scientific article

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

scientific article published on 4 January 2012

Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey

scientific article

Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

scientific article

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey

scientific article

Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma

scientific article

New developments of aminobisphosphonates: the double face of Janus.

scientific article published on June 2007

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron.

scientific article published on June 2005

New frontiers in the medical management of gastrointestinal stromal tumours.

scientific article published on 17 May 2019

New issues on cetuximab mechanism of action in epidermal growth factor receptor-negative colorectal cancer: the role of vascular endothelial growth factor

scientific article published on 01 April 2006

New molecular targets in bone metastases.

scientific article

New perspectives: role of Sunitinib in breast cancer.

scientific article published on May 2011

New perspectives: role of sunitinib in breast cancer.

scientific article published on September 2010

New target agents in the treatment of colorectal cancer patients

scientific article published on June 2007

New targets, new drugs for metastatic bone pain: a new philosophy.

scientific article

New therapies in soft tissue sarcoma.

scientific article published on June 2010

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

scientific article published on June 2005

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

scientific article published on 25 October 2005

Nutrition in patients with cancer: a new area for medical oncologists? A practising oncologist's interdisciplinary position paper.

scientific article

Occasional FDG PET recognition of in situ breast cancer

scientific article published in September 2007

Ocular toxicity related to cetuximab monotherapy in an advanced colorectal cancer patient

scientific article published on 01 April 2005

Oncosuppressor methylation: A possible key role in colon metastatic progression

scientific article published on 01 July 2011

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer.

scientific article published on 5 May 2018

Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study

scientific article published on 20 July 2005

Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology

scientific article published on 13 April 2016

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

scientific article published on 7 August 2017

Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study

scientific article

Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients

scientific article published on April 2002

PD-1 blockade therapy in renal cell carcinoma: current studies and future promises.

scientific article

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

scientific article

PML as a potential predictive factor of oxaliplatin/fluoropyrimidine-based first line chemotherapy efficacy in colorectal cancer patients

scientific article published on 01 March 2012

PML down-regulation in soft tissue sarcomas

scientific article published in September 2010

PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy

scientific article published on 01 April 2012

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

scientific article published on 27 April 2009

Pain related to cancer treatments and diagnostic procedures: a no man's land?

scientific article

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

scientific article published on 10 December 2018

Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

scientific article

Pancreatic intraductal papillary mucinous neoplasms: a paradigmatic case. A case report and review of the literature

scientific article published on July 2008

Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature

scientific article published on 14 August 2008

Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways.

scientific article published on 24 October 2013

Paraneoplastic syndromes: what we know and what we should know

scientific article published on 01 March 2006

Pazopanib and pancreatic toxicity: a case report.

scientific article published on 14 May 2015

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

scientific article published on 10 January 2013

Percutaneous Long Bone Cementoplasty for Palliation of Malignant Lesions of the Limbs: A Systematic Review

scientific article published on 24 March 2015

Perspectives in the elderly patient: benefits and limits of bisphosphonates and denosumab

scientific article published on January 2012

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

scientific article published on 01 April 2006

Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer

scientific article

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy

scientific article published on 01 April 2007

Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.

scientific article

Phase I study of intermittent and chronomodulated oral therapy with capecitabine in patients with advanced and/or metastatic cancer

scientific article

Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer

scientific article published on 01 January 2007

Potential role of everolimus in inducing cholestasis

scientific article published on 2 December 2009

Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules.

scientific article

Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study

scientific article

Predictive factors for chemotherapy-related toxic effects in patients with colorectal cancer.

scientific article published on 10 June 2008

Predictive factors for response to chemotherapy in colorectal cancer patients

scientific article published in October 2004

Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence.

scientific article

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

scientific article published on 19 May 2016

Premetastatic niche: ready for new therapeutic interventions?

scientific article published on 23 March 2012

Presurgical window of opportunity trial design as a platform for testing anticancer drugs: Pros, cons and a focus on breast cancer

scientific article published on 21 August 2016

Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron.

scientific article published in January 2001

Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer.

scientific article

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

scientific article published on 31 July 2015

Prognostic Role ofInterleukin-1βGene andInterleukin-1 Receptor AntagonistGene Polymorphisms in Patients With Advanced Gastric Cancer

article

Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.

scientific article published in May 2010

Prognostic role of thymidylate synthase polymorphisms in gastric cancer patients treated with surgery and adjuvant chemotherapy

scientific article published on 01 May 2005

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

scientific article published on 19 August 2015

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

scientific article published on 6 January 2015

Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma.

scientific article published on February 2005

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

scientific article

Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis.

scientific article

Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.

scientific article published on 9 August 2008

Pseudocirrhosis after anti-EGFR-based neoadjuvant therapy for hepatic metastasis from colon cancer: a different point of view

scientific article published on 26 June 2014

Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy".

scientific article published on 28 January 2014

R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation

scientific article published on May 2007

Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer

scientific article

Raltitrexed as monochemotherapy induces a statistically significant increase in platelet count

scientific article published in January 2002

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).

scientific article

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study.

scientific article published in January 2004

Raltitrexed-induced hepatotoxicity: multivariate analysis of predictive factors

scientific article published in August 2003

Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain

scientific article published on 7 December 2015

Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542-3.

scientific article published on 29 September 2015

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients

scientific article (publication date: 29 April 2011)

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.

scientific article

Recurrent episodes of involuntary masticatory spasms induced by continuous infusion of oxaliplatin

scientific article published in October 2003

Recurrent scrotal hemangiomas during treatment with sunitinib.

scientific article published on 7 September 2010

Recurrent thrombophlebitis in a colon cancer patient with C677T heterozygous genotype for MTHFR treated with 5-fluorouracil-based adjuvant chemotherapy

scientific article published on 23 September 2004

Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade.

scientific article

Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

scientific article

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

scientific article

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials

scientific article

Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials

scientific article published on 09 June 2015

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

scientific article published on 23 March 2016

Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance

scientific article

Role of GPR30 in testicular germ cell tumors: a potential new anticancer target

scientific article published on 15 April 2011

Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

scientific article

Role of STAT3 pathway in genitourinary tumors.

scientific article published on November 2015

Role of c-mesenchymal-epithelial transition pathway in gastric cancer.

scientific article published on 16 April 2015

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis ⬇️

scientific article published on 17 May 2015

Role of natural and adaptive immunity in renal cell carcinoma response to VEGFR-TKIs and mTOR inhibitor.

scientific article

S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury.

scientific article published in November 2003

Safety and clinical outcome of a cohort of patients (pts) with castration resistant prostate cancer (CRPC) treated with abiraterone acetate (AA) in a named patient program (NPP): Updated results of a retrospective study from an Italian cooperative gr

article

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

scientific article published on November 2008

Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

scientific article

Second-line chemotherapy in advanced biliary cancer: the present now will later be past

scientific article published on 13 August 2014

Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: it is not about the destination, it is about the journey

scientific article

Sequential administration of new agents (NAs) after docetaxel (DOC) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Impact of disease control (DC) duration in second line on the subsequent line outcomes

Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

scientific article published on 12 January 2012

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw.

scientific article published on 17 September 2012

Severe liver dysfunction after raltitrexed administration in an HCV-positive colorectal cancer patient

scientific article published in January 2003

Should oncologists be aware in their clinical practice of KRAS molecular analysis?

scientific article

Single colonic metastasis from breast cancer 11 years after mastectomy

scientific article published on 6 July 2015

Skin Lesions in Melanoma and Kaposi’s Sarcoma

scientific article published on 01 March 2002

Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience

scientific article

Spatial brain distribution of intra-axial metastatic lesions in breast and lung cancer patients.

scientific article published on 18 July 2012

Statins may potentiate bisphosphonates anticancer properties: a new pharmacological approach?

scientific article published on July 2003

Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab

scientific article published on 19 February 2009

Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?

scientific article

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

scientific article published on 18 July 2014

Surgical complications after resection of adrenal carcinoma

scientific article published on 01 September 2006

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

scientific article published on 4 December 2014

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.

scientific article

Target therapies in pancreatic carcinoma.

scientific article published on January 2014

Target therapy in gastrointestinal tract sarcoma: What is new?

scientific article published on January 2010

Target therapy of bone metastases and tumours

scientific article published on 01 November 2009

Targeted therapy in biliary tract cancer: 2009 update.

scientific article published on December 2009

Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside.

scientific article published on 20 October 2011

Targeting EGFR in bilio-pancreatic and liver carcinoma

scientific article published on January 2011

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

scientific article published on December 2007

Targeting bone metastases starting from the preneoplastic niche: home sweet home

scientific article published on 16 August 2011

Targeting bone metastatic cancer: Role of the mTOR pathway

scientific article published on 05 February 2014

Taxanes in adjuvant chemotherapy for early breast cancer

scientific article published on 01 May 2006

The Italian cross-sectional survey of the management of bone metastasis: ZeTa study

scientific article

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

scientific article published on 4 September 2015

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

scientific article published on October 2003

The antineoplastic treatment in the elderly.

scientific article

The biological properties of cetuximab

scientific article published on 03 August 2008

The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker?

scientific article

The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinoma

scientific article published on January 2009

The distinctive molecular, pathological and clinical characteristics of BRAF-mutant colorectal tumors

scientific article published on 15 May 2015

The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials

scientific article published on 16 October 2017

The immunocheckpoints in modern oncology: the next 15 years.

scientific article published in July 2015

The new era in the treatment of advanced colorectal cancer patients: the role of monoclonal antibodies.

scientific article published on November 2006

The origin of prostate metastases: emerging insights.

scientific article published on 12 September 2015

The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein.

scientific article published in November 2009

The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy

scientific article

The role of Aurora-A inhibitors in cancer therapy.

scientific article published on June 2007

The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen

scientific article published on 15 March 2011

The role of bone microenvironment, vitamin D and calcium.

scientific article published on January 2012

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

scientific article

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

scientific article published on 9 March 2017

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

scientific article

The route to personalized medicine in bladder cancer: where do we stand?

scientific article

The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrence

scientific article (publication date: 2013)

Thymidylate synthase expression in colorectal cancer: the never-ending story

scientific article published on 01 March 2005

Thymidylate synthase expression in normal colonic mucosa: a predictive marker of toxicity in colorectal cancer patients receiving 5-fluorouracil-based adjuvant chemotherapy.

scientific article published in January 2004

Tissue engineering and microRNAs: future perspectives in regenerative medicine

scientific article published on 22 July 2015

Tissue invasion and metastasis: Molecular, biological and clinical perspectives

scientific article published on 09 April 2015

Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer.

scientific article published in September 2002

Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes

scientific article published on 29 September 2008

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer

scientific article

Tumour proliferation, angiogenesis, and ploidy status in human colon cancer

scientific article published on November 2005

Unusual Problems in Breast Cancer and a Rare Lung Cancer Case

scientific article published on 01 June 2003

Update on capecitabine alone and in combination regimens in colorectal cancer patients

scientific article

Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma

scientific article published on 29 April 2008

Use of the word “cured” for cancer patients—implications for patients and physicians: the Siracusa charter.

scientific article published in February 2015

VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.

scientific article

Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer

scientific article published on 23 December 2008

Vascular endothelial growth factor (VEGF) expression is not associated with prognosis in patients with radically resected ampullary carcinoma

scientific article published on 21 June 2005

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

scientific article published on 10 May 2006

Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study

scientific article published on 06 July 2019

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

scientific article published on 11 April 2015

What can we learn from the ZOOM trial?--Authors' reply

scientific article

Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives

scientific article published on June 2010

Will trastuzumab change the optimal adjuvant systemic therapy of patients with HER2-positive breast cancer?

scientific article published on 01 January 2006

Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?

scientific article published on 5 June 2015

Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma

scientific article published in May 2004

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.

scientific article published in August 2003

Zoledronic acid for the treatment of appendicular osteosarcoma in a dog.

scientific article

Zoledronic acid in the management of metastatic bone disease.

scientific article published on December 2006

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting

scientific article published on 3 December 2013

Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.

scientific article published on August 2003

Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients

scientific article published on March 2005

[Immunotherapy in non-small cell lung cancer patients: back to the future.]

scientific article published on 01 December 2019

[The prevention of vomiting due to antineoplastic chemotherapy in the elderly cancer patient]

scientific article published on 01 July 1999

cDNA array technology in melanoma: an overview.

scientific article

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.

scientific article

Paulina is supported by:

About Paulina

Help